Gene · 4157
Papers3,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Determination of the Interaction and Pharmacological Modulation of MCHR1 Signaling by the C-Terminus of MRAP2 Protein. | Front Endocrinol (Lausanne) | 2022 | 35311242 | PubTator, text mining | PubMed |
| A general framework for identifying oligogenic combinations of rare variants in complex disorders. | Genome Res | 2022 | 35301265 | PubTator, text mining | PubMed |
| Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma. | BMC Med Genomics | 2022 | 35300699 | PubTator, text mining | PubMed |
| Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia. | Front Immunol | 2022 | 35300332 | PubTator, text mining | PubMed |
| Genetic ancestry in precision medicine is reshaping the race debate. | Proc Natl Acad Sci U S A | 2022 | 35294278 | PubTator, text mining | PubMed |
| Molecular basis for allosteric agonism and G protein subtype selectivity of galanin receptors. | Nat Commun | 2022 | 35292680 | PubTator, text mining | PubMed |
| Interplay Between the Immune and Endocrine Systems in the Lung: Implications for TB Susceptibility. | Front Immunol | 2022 | 35273609 | PubTator, text mining | PubMed |
| Interferon-gamma induces melanogenesis via post-translational regulation of tyrosinase. | Pigment Cell Melanoma Res | 2022 | 35266648 | PubTator, text mining | PubMed |
| RNA-seq and integrated network analysis reveals the hub genes and key pathway of paclitaxel inhibition on Adriamycin resistant diffuse large B cell lymphoma cells. | Bioengineered | 2022 | 35263200 | PubTator, text mining | PubMed |
| Melanoma therapeutics: a literature review. | J Biomed Res | 2022 | 35260531 | PubTator, text mining | PubMed |
| Sebocytes contribute to melasma onset. | iScience | 2022 | 35252805 | PubTator, text mining | PubMed |
| Integrated Analysis of DNA Repair Genes Identifies SLC6A1 as a New Marker for the Clinical Outcome of Patients with Colorectal Cancer. | Dis Markers | 2022 | 35251372 | PubTator, text mining | PubMed |
| Pharmacological Evaluation of Melanocortin 2 Receptor Accessory Protein 2 on Axolotl Neural Melanocortin Signaling. | Front Endocrinol (Lausanne) | 2022 | 35250878 | PubTator, text mining | PubMed |
| Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression. | Tzu Chi Med J | 2022 | 35233349 | PubTator, text mining | PubMed |
| Uncovering a Hub Signaling Pathway of Antimicrobial-Antifungal-Anticancer Peptides' Axis on Short Cationic Peptides via Network Pharmacology Study. | Int J Mol Sci | 2022 | 35216171 | PubTator, text mining | PubMed |
| A Mixture of Topical Forms of Polydeoxyribonucleotide, Vitamin C, and Niacinamide Attenuated Skin Pigmentation and Increased Skin Elasticity by Modulating Nuclear Factor Erythroid 2-like 2. | Molecules | 2022 | 35209068 | PubTator, text mining | PubMed |
| Effectiveness of ACTH in Patients with Infantile Spasms. | Brain Sci | 2022 | 35204017 | PubTator, text mining | PubMed |
Diarylpropionitrile inhibits melanogenesis via protein kinase A/cAMP-response element-binding protein/microphthalmia-associated transcription factor signaling pathway in α-MSH-stimulated B16F10 melanoma cells. | Korean J Physiol Pharmacol | 2022 | 35203061 | PubTator, text mining | PubMed |
| Structural and Functional Diversity of Animal Toxins Interacting With GPCRs. | Front Mol Biosci | 2022 | 35198603 | PubTator, text mining | PubMed |
| Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson's disease. | Mol Neurodegener | 2022 | 35197079 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4157/papers?page=38